2015
Psychosocial and metabolic function by smoking status in individuals with binge eating disorder and obesity
Udo T, White MA, Barnes RD, Ivezaj V, Morgan P, Masheb RM, Grilo CM. Psychosocial and metabolic function by smoking status in individuals with binge eating disorder and obesity. Addictive Behaviors 2015, 53: 46-52. PMID: 26451703, PMCID: PMC4679522, DOI: 10.1016/j.addbeh.2015.09.018.Peer-Reviewed Original ResearchConceptsTreatment-seeking adultsTreatment-seeking patientsSubstance use disordersDisorder psychopathologyCurrent smokersFormer smokersPsychosocial functioningComorbid psychiatric disordersSmoking statusLifetime psychiatric comorbidityUse disordersLifetime diagnostic criteriaPotential long-term implicationsFunctioningBingePsychiatric comorbidityMeeting criteriaPsychiatric disordersMetabolic functionsMetabolic functioningMetabolic riskMetabolic syndromeMetabolic abnormalitiesSmoking cessationSmokers
2010
Effect of Binge Eating on Treatment Outcomes for Smoking Cessation
White MA, Peters EN, Toll BA. Effect of Binge Eating on Treatment Outcomes for Smoking Cessation. Nicotine & Tobacco Research 2010, 12: 1172-1175. PMID: 20889472, PMCID: PMC2964923, DOI: 10.1093/ntr/ntq163.Peer-Reviewed Original ResearchConceptsEffects of bingeSmoking cessationBingeing Severity ScaleLarge clinical trialsEmergence of bingeSelf-report questionnaire itemsMore weight gainLower quit ratesAbstinence ratesCessation outcomesClinical trialsQuit ratesTreatment outcomesSeverity ScaleBinge eatingWeight gainBingeParticipant groupsBaselineCessationFollowParticipantsQuestionnaire itemsOutcomesTreatmentSelf‐reported weight gain following smoking cessation: A function of binge eating behavior
White MA, Masheb RM, Grilo CM. Self‐reported weight gain following smoking cessation: A function of binge eating behavior. International Journal Of Eating Disorders 2010, 43: 572-575. PMID: 19718662, PMCID: PMC2895960, DOI: 10.1002/eat.20729.Peer-Reviewed Original ResearchLow-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial
Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O’Malley S. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial. Drug And Alcohol Dependence 2010, 111: 200-206. PMID: 20542391, PMCID: PMC3771701, DOI: 10.1016/j.drugalcdep.2010.04.015.Peer-Reviewed Original ResearchConceptsWeight gainSmoking cessationPoint prevalence smoking abstinence ratePre-specified primary outcomesLow-dose naltrexoneOpen-label therapySmoking abstinence ratesPoint prevalence abstinenceReduced weight gainNaltrexone augmentationPlacebo groupNicotine replacementPrimary outcomeQuit dateAbstinence ratesLabel therapyNicotine patchBehavioral counselingNaltrexoneAbstinent participantsSmokersWeight concernsWeeksCessationLower rates
2007
Smoke and mirrors: Magnified beliefs that cigarette smoking suppresses weight
White MA, McKee SA, O'Malley SS. Smoke and mirrors: Magnified beliefs that cigarette smoking suppresses weight. Addictive Behaviors 2007, 32: 2200-2210. PMID: 17428615, PMCID: PMC1993360, DOI: 10.1016/j.addbeh.2007.02.011.Peer-Reviewed Original ResearchConceptsSmoking Consequences Questionnaire-AdultWeight concernsWeight-concerned smokersAbility of smokingControl scoresBingeing Severity ScaleWeight-concerned individualsEffectiveness of smokingBody dissatisfactionLoss of controlActual weight gainMagical thinkingExaggerated beliefsPrevious quit attemptsSmoking cessationWeight gainQuit attemptsWeight control strategiesCessation trialTemporary abilitySuppress body weightFood rulesCurrent studyPerceived RiskBeliefs